SABS - SAB Biotherapeutics, Inc.
IEX Last Trade
3.66
-0.180 -4.918%
Share volume: 57,960
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$3.84
-0.18
-0.05%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2023-05-15 | 2023-08-21 | 2023-11-13 | 2024-03-29 | 2024-05-20 | 2024-08-08 | 2024-11-06 | |
| Cash flow financing | -359.790 K | -363.788 K | -140.308 K | 67.637 M | -394.418 K | -321.039 K | -674.130 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -101.390 K | -58.312 K | |
| Cash flow | -1.606 M | -4.899 M | -5.168 M | -13.447 M | -10.750 M | 3.180 M | -8.119 M | |
| Net income | -7.354 M | -6.881 M | -5.102 M | -22.857 M | -5.026 M | -7.335 M | -10.349 M | |
| Depreciation | 923.169 K | 892.266 K | 985.446 K | 944.401 K | 1.985 M | 1.034 M | 945.154 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 763.123 K | 364.117 K | 0.000 | 0.000 | 193.232 K | 0.000 | 0.000 | |
| Investing Cashflow | -21.300 K | -22.684 K | -40.856 K | -67.864 K | -31.359 M | 11.219 M | -1.153 M | |
| Net Borrowings | -8.808 M | -3.738 M | 1.525 M | -53.000 M | -41.307 M | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -21.300 K | -22.684 K | -85.306 K | -67.864 K | -129.074 K | 52.511 K | 100.300 K | |
| Cash Change | 13.060 M | 7.774 M | 2.425 M | 56.566 M | 44.057 M | 3.208 M | -8.071 M |